Current Recruitment

red-content-divider.png

Current Recruitment

Central Florida Retina is currently enrolling patients who are interested in participating in one of the following studies.

 

For patients who have been diagnosed with Age Related Macular Degeneration

1.     Alcon
Testing a new investigational drug in the form of an eye drop for patients who have been diagnosed with Wet or Dry AMD

2.     Acucela
Phase 2b study for patients with Dry AMD specific to Geographic Atrophy.

3.     Ophthotech
Phase 3 study for patients with Wet AMD using mono therapy.

 

For patients who have been diagnosed with Alzheimer Disease

Merck

Phase 2/3 study to examine and test for retinal effects and visual changes while being administered disease specific study drug for dementia.

Genetic Studies

GARM II

Study designed to observe and identify the risk factors that contribute to genetic Age Related Macular Degeneration.

eyeGENE

Study designed to assist in Blood/DNA collection for the National Ophthalmic Disease Genotyping and Phenotyping Network.

Attention Patients and Doctors

If you are interested in obtaining more information or would like to enroll in one of these studies, please contact CFR’s Clinical Research Department at clinicalresearch@cfretina.com.